physIQ Heart Rhythm and Respiratory Module vs Cardiomo

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Cardiomo, Inc.

AI Verdict

Both physIQ Heart Rhythm and Respiratory Module and Cardiomo offer AI-powered platforms for continuous remote heart health monitoring using wearable biosensors, making them direct competitors. While physIQ emphasizes personalized physiology analytics and FDA-cleared digital biomarkers for a broader range of physiological changes, Cardiomo focuses on a medical-grade wearable patch for vital sign monitoring and specific cardiovascular disease detection with real-time alerts and fall detection.

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if your primary need is continuous, long-term remote patient monitoring using wearable biosensor data, particularly for detecting subtle physiological changes and early signs of decompensation in heart rhythm and respiration. This platform is ideal for managing chronic conditions or post-acute care, as it establishes a personalized physiological baseline for each patient and provides FDA-cleared analytics for conditions like atrial fibrillation and respiratory distress.

View physIQ Heart Rhythm and Respiratory Module →

Choose Cardiomo if…

Choose Cardiomo if you require a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring with real-time alerts for users and caregivers. This tool is well-suited for detecting cardiovascular diseases, including arrhythmias and potential cardiovascular events, and offers features like continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature) and fall detection with a long battery life.

View Cardiomo →

When choosing between physIQ Heart Rhythm and Respiratory Module and Cardiomo, physicians should consider their primary focus and patient population. PhysIQ excels in continuous, personalized physiological analytics, leveraging a cloud platform to process data from various wearable biosensors. Its strength lies in establishing individual patient baselines and detecting subtle changes, making it suitable for proactive monitoring and early decompensation detection in cardiology, critical care, and pulmonology. The platform’s ability to learn an individual’s baseline and detect subtle physiological changes is a key differentiator, offering a highly personalized monitoring approach.

Cardiomo, on the other hand, provides a medical-grade wearable device integrated with an AI-powered platform for continuous heart health monitoring. It focuses on detecting cardiovascular diseases and delivering timely alerts, with features like ECG, heart rate, respiration, and fall detection. Cardiomo’s integrated wearable and real-time alert system may be more appealing for physicians prioritizing a complete, out-of-the-box solution for remote patient monitoring, particularly in cardiology, geriatrics, and internal medicine. The practical difference lies in physIQ’s agnostic approach to biosensors and its emphasis on personalized baseline analytics versus Cardiomo’s integrated device and direct disease detection alerts. Physicians seeking a flexible platform for advanced, personalized physiological insights across various biosensors might prefer physIQ, while those desiring a comprehensive, medical-grade wearable solution with direct alerts for cardiovascular events may find Cardiomo more aligned with their needs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature physIQ Heart Rhythm and Respiratory Module Cardiomo
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based platform Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiomo

Cardiomo appears to offer a more direct and user-friendly experience for patients and caregivers through its wearable patch and mobile app, providing real-time alerts and color-coded messages for easy interpretation. PhysIQ, while powerful, seems more geared towards healthcare professionals interpreting complex data and trends.

Clinical Value

physIQ Heart Rhythm and Respiratory Module

PhysIQ stands out with its FDA-cleared analytics and digital biomarkers, which are crucial for clinical credibility. Its ability to learn individual patient baselines and detect subtle physiological changes for early decompensation across both cardiac and respiratory functions offers a broad and validated approach to proactive care.

Pricing & Value

Tie

Both tools require contacting the company for current pricing, making a direct comparison difficult. While Cardiomo previously offered a public price, it is no longer current. Therefore, without transparent pricing, it's a tie.

Enterprise Readiness

physIQ Heart Rhythm and Respiratory Module

PhysIQ explicitly states it is an 'industry-leading, enterprise-ready cloud platform' and directly claims HIPAA compliance and the availability of a Business Associate Agreement (BAA). Cardiomo also states HIPAA compliance and BAA availability, but physIQ's emphasis on an 'enterprise-ready' platform suggests a more robust offering for larger organizations.

Innovation

physIQ Heart Rhythm and Respiratory Module

PhysIQ's core innovation lies in its AI-based personalized physiology analytics, which learns individual patient baselines to detect subtle, early signs of decompensation across cardiac and respiratory parameters. This represents a sophisticated and fundamental application of AI for predictive health insights from continuous wearable data.

Support & Docs

Tie

Neither tool provides extensive public information regarding their support and documentation. Without more detailed information on available resources like knowledge bases, dedicated support teams, or training materials, it is difficult to distinguish between the two.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature physIQ Heart Rhythm and Respiratory Module Cardiomo
Company physIQ Cardiomo, Inc.
Key Features (Heart Rate Monitoring) Calculates heart rate and heart rate variability Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature)
Key Features (Respiration Monitoring) Determines respiration rate Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature)
Key Features (Atrial Fibrillation Detection) Detects atrial fibrillation AI-powered disease detection (arrhythmias, cardiovascular events)
Specialties Cardiology, Critical Care, Pulmonology Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

PhysIQ is an enterprise-ready cloud platform, and while the depth of its EHR integration isn't explicitly detailed, it focuses on continuous data collection and analytics for proactive insights. Cardiomo utilizes a mobile app and a HIPAA-compliant cloud analytics system, with data channeled via a proprietary mobile app to a secure cloud. Both aim to provide real-time data for doctors online, suggesting a workflow where physicians access insights through their respective platforms.
PhysIQ's FDA-cleared analytics are designed to detect subtle physiological changes and early signs of decompensation, including atrial fibrillation, heart rate, heart rate variability, and respiration rate, by learning individual patient baselines. Cardiomo claims 99.63% accuracy in detecting cardiac events and providing early life-saving alerts, monitoring vital signs like ECG, heart rate, respiration rate, and skin temperature. Cardiomo's sensors achieve 99.2% clinical accuracy, validated through clinical studies.
PhysIQ's usability is likely centered on dashboard interpretation of alerts and trends from continuous data collection and analytics. Cardiomo is described as highly reliable, flexible, practical, and user-friendly, with its AI analyzing data to provide more accurate diagnoses. Generally, AI-guided technology can facilitate cardiac imaging and shorten training for novice operators.
The provided information does not offer specific details about the availability, scope, or quality of customer support, training, or comprehensive product documentation for either physIQ or Cardiomo. Therefore, a direct comparison of support quality is not possible from the given facts.
Cardiomo's security measures include role-based access control (RBAC) where all access is logged and audited. The information provided for physIQ does not explicitly detail its audit-trail features beyond being a HIPAA-compliant, enterprise-ready cloud platform.
PhysIQ is an industry-leading, enterprise-ready cloud platform, suggesting it is built for scalability across multiple sites. Cardiomo is a cloud-based platform with a mobile app, which inherently supports remote access and data management. While both are cloud-based, specific features for managing multi-site rollouts are not detailed.

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.